The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Cardiome Pharma Corp up $0.03

Cardiome Pharma Corp is up today by $0.03 or 0.80% to $3.77. Over the last five days, shares have gained 6.20%, but are down 66.13% for the last year to date. Shares have underperformed the S&P TSX by 85.78% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.31
Updated December 7 3:12 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-93.38%

Although this company's net profit margin is negative, it is above the industry average and implies that Cardiome Pharma Corp is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.70%Sector:HealthcareIndustry:Biotechnology

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue5675
Total other revenue--------
Total revenue5675
Gross profit4462
Total cost of revenue1213
Total operating expense912812
Selling / general / administrative7868
Research & development0000
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)01----
Other operating expenses, total--------
Operating income-4-6-1-7
Interest income (expense), net non-operating-1000
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-7-1-8
Income after tax-5-8-1-7
Income tax, total0000
Net income-5-8-1-7
Total adjustments to net income--------
Net income before extra. items-5-8-1-7
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5-8-1-7
Inc. avail. to common incl. extra. items-5-8-1-7
Diluted net income-5-8-1-7
Dilution adjustment--------
Diluted weighted average shares28202020
Diluted EPS excluding extraordinary itemsvalue per share-0.19-0.37-0.06-0.37
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.19-0.32-0.06-0.37